Atrion Corp (ATRI)
444.64
+16.84
(+3.94%)
USD |
NASDAQ |
May 10, 16:00
444.64
0.00 (0.00%)
After-Hours: 20:00
Atrion Cash from Financing (TTM): -17.04M for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -17.04M |
September 30, 2023 | -23.82M |
June 30, 2023 | -29.70M |
March 31, 2023 | -38.51M |
December 31, 2022 | -41.04M |
September 30, 2022 | -29.40M |
June 30, 2022 | -30.30M |
March 31, 2022 | -34.14M |
December 31, 2021 | -30.98M |
September 30, 2021 | -32.46M |
June 30, 2021 | -25.65M |
March 31, 2021 | -22.66M |
December 31, 2020 | -30.99M |
September 30, 2020 | -28.87M |
June 30, 2020 | -28.55M |
March 31, 2020 | -20.95M |
December 31, 2019 | -11.33M |
September 30, 2019 | -10.96M |
June 30, 2019 | -10.59M |
March 31, 2019 | -9.817M |
December 31, 2018 | -9.538M |
September 30, 2018 | -9.26M |
June 30, 2018 | -8.981M |
March 31, 2018 | -13.07M |
December 31, 2017 | -16.05M |
Date | Value |
---|---|
September 30, 2017 | -15.74M |
June 30, 2017 | -15.44M |
March 31, 2017 | -11.79M |
December 31, 2016 | -9.499M |
September 30, 2016 | -9.219M |
June 30, 2016 | -14.57M |
March 31, 2016 | -21.29M |
December 31, 2015 | -36.76M |
September 30, 2015 | -48.07M |
June 30, 2015 | -42.72M |
March 31, 2015 | -41.65M |
December 31, 2014 | -29.20M |
September 30, 2014 | -22.64M |
June 30, 2014 | -23.17M |
March 31, 2014 | -17.80M |
December 31, 2013 | -14.00M |
September 30, 2013 | -28.58M |
June 30, 2013 | -27.24M |
March 31, 2013 | -28.80M |
December 31, 2012 | -28.80M |
September 30, 2012 | -8.831M |
June 30, 2012 | -10.22M |
March 31, 2012 | -6.479M |
December 31, 2011 | -5.188M |
September 30, 2011 | -10.97M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-41.04M
Minimum
Dec 2022
-10.59M
Maximum
Jun 2019
-26.21M
Average
-28.87M
Median
Sep 2020
Cash from Financing (TTM) Benchmarks
Perspective Therapeutics Inc | 0.785M |
Retractable Technologies Inc | 0.9416M |
Xtant Medical Holdings Inc | 19.69M |
Asensus Surgical Inc | 9.626M |
Catheter Precision Inc | 8.386M |